PEPGEN INC. Basic Shares Outstanding (Weighted Average)
PEPGEN INC. (PEPG) reported Basic Shares Outstanding (Weighted Average) of 69.20 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- PEPGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 69.20M shares, a 111.31% increase year-over-year.
- PEPGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 69.09M shares, a 111.45% increase year-over-year.
- PEPGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 69.08M shares, a 111.84% increase year-over-year.
- PEPGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 34.36M shares, a 5.47% increase year-over-year.
- PEPGEN INC. weighted average number of shares outstanding, basic for fiscal 2025 was 42.22M shares, a 33.68% increase from fiscal 2024.
- PEPGEN INC. weighted average number of shares outstanding, basic for fiscal 2024 was 31.58M shares, a 32.72% increase from fiscal 2023.
- PEPGEN INC. weighted average number of shares outstanding, basic for fiscal 2023 was 23.80M shares, a 52.15% increase from fiscal 2022.
- PEPGEN INC. weighted average number of shares outstanding, basic for fiscal 2022 was 15.64M shares, a 1635.61% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 69.20M shares 10-Q · filed 2026-08-06 | 69.15M shares 10-Q · filed 2026-08-06 | 69.13M shares derived: average of 3 quarters · filed 2026-08-06 | 60.43M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 69.09M shares 10-Q · filed 2026-05-12 | 69.09M shares derived: average of 2 quarters · filed 2026-05-12 | 57.51M shares derived: average of 3 quarters · filed 2026-05-12 | 51.32M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 69.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 51.72M shares derived: average of 2 quarters · filed 2026-03-04 | 45.40M shares derived: average of 3 quarters · filed 2026-08-06 | 42.22M shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 34.36M shares 10-Q · filed 2025-11-12 | 33.56M shares derived: average of 2 quarters · filed 2026-08-06 | 33.27M shares 10-Q · filed 2025-11-12 | 33.10M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 32.75M shares 10-Q · filed 2026-08-06 | 32.71M shares 10-Q · filed 2026-08-06 | 32.68M shares derived: average of 3 quarters · filed 2026-08-06 | 32.65M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 32.67M shares 10-Q · filed 2026-05-12 | 32.64M shares derived: average of 2 quarters · filed 2026-05-12 | 32.62M shares derived: average of 3 quarters · filed 2026-05-12 | 32.58M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 32.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 32.60M shares derived: average of 2 quarters · filed 2026-03-04 | 32.55M shares derived: average of 3 quarters · filed 2026-03-04 | 31.58M shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 32.58M shares 10-Q · filed 2025-11-12 | 32.53M shares derived: average of 2 quarters · filed 2025-11-12 | 31.24M shares 10-Q · filed 2025-11-12 | 29.38M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 32.47M shares 10-Q · filed 2025-08-07 | 30.56M shares 10-Q · filed 2025-08-07 | 28.31M shares derived: average of 3 quarters · filed 2025-08-07 | 27.18M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 28.66M shares 10-Q · filed 2025-05-08 | 26.24M shares derived: average of 2 quarters · filed 2025-05-08 | 25.42M shares derived: average of 3 quarters · filed 2025-05-08 | 25.01M shares derived: average of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 23.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | 23.80M shares derived: average of 2 quarters · filed 2025-02-24 | 23.80M shares derived: average of 3 quarters · filed 2025-02-24 | 23.80M shares 10-K · filed 2025-02-24 |
| 2023-09-30 | 23.79M shares 10-Q · filed 2024-11-07 | 23.79M shares derived: average of 2 quarters · filed 2024-11-07 | 23.79M shares 10-Q · filed 2024-11-07 | 23.76M shares derived: average of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 23.79M shares 10-Q · filed 2024-08-08 | 23.78M shares 10-Q · filed 2024-08-08 | 23.75M shares derived: average of 3 quarters · filed 2024-08-08 | 23.70M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 23.76M shares 10-Q · filed 2024-05-14 | 23.73M shares derived: average of 2 quarters · filed 2024-05-14 | 23.67M shares derived: average of 3 quarters · filed 2024-05-14 | 21.28M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 23.69M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-29 | 23.63M shares derived: average of 2 quarters · filed 2024-03-29 | 20.45M shares derived: average of 3 quarters · filed 2024-03-29 | 15.64M shares 10-K/A · filed 2024-03-29 |
| 2022-09-30 | 23.56M shares 10-Q · filed 2023-11-08 | 18.83M shares derived: average of 2 quarters · filed 2023-11-08 | 12.95M shares 10-Q · filed 2023-11-08 | 9.88M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 14.09M shares 10-Q · filed 2023-08-08 | 7.56M shares 10-Q · filed 2023-08-08 | 5.33M shares derived: average of 3 quarters · filed 2023-08-08 | 4.22M shares derived: average of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 963.59K shares 10-Q · filed 2023-05-11 | 942.92K shares derived: average of 2 quarters · filed 2023-05-11 | 926.63K shares derived: average of 3 quarters · filed 2023-05-11 | 918.49K shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 922.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 908.16K shares derived: average of 2 quarters · filed 2023-03-23 | 903.46K shares derived: average of 3 quarters · filed 2023-03-23 | 901.11K shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 894.06K shares 10-Q · filed 2022-11-10 | 894.06K shares derived: average of 2 quarters · filed 2022-11-10 | 894.06K shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 894.06K shares 10-Q · filed 2022-08-12 | 894.06K shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |